Post-transplant maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation harmonizing multiple therapeutic modalities including targeted therapy, immunotherapy and cellular therapy Eshrak AL-ShaibaniIgor Novitzky-BassoDennis Dong Hwan Kim Review Article 22 May 2023 Pages: 1 - 17
Effect of delivery mode on postnatal platelet count dynamics in neonates born to mothers with immune thrombocytopenia Shoichiro WadaKousaku MatsubaraYoshimichi Yamaguchi Original Article 22 March 2023 Pages: 18 - 25
Identification of a novel mutation in the factor XIII A subunit in a patient with inherited factor XIII deficiency Lijie YanTiantian WangZi Sheng Original Article 14 April 2023 Pages: 26 - 35
Prognostic impact of FLT3-ITD, NPM1 mutation and CEBPA bZIP domain mutation in cytogenetically normal acute myeloid leukemia: a Hokkaido Leukemia Net study Naoki MiyashitaMasahiro OnozawaTakanori Teshima Original Article 28 February 2023 Pages: 36 - 46
Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis Yoko EdahiroTomonori OchiaiNorio Komatsu Original Article 14 April 2023 Pages: 47 - 53
Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells Yoji HiraiKeiji IwatsukiShin Morizane Original Article Open access 03 May 2023 Pages: 54 - 64
EBF1–JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity Yukino KojimaFumika KawashimaFumihiko Hayakawa Original Article 07 May 2023 Pages: 65 - 74
CD30 stimulation induces multinucleation and chromosomal instability in HTLV-1-infected cell lines Mariko WatanabeHiromi HatsuseRyouichi Horie Original Article 04 April 2023 Pages: 75 - 87
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors Emiko NakaueJumpei TeramachiMasahiro Abe Original Article Open access 11 April 2023 Pages: 88 - 98
Outcomes following induction failure in Japanese children with acute lymphoblastic leukemia Chihaya ImaiAtsushi SatoYasuhiro Okamoto Original Article 10 April 2023 Pages: 99 - 106
Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study Akira MorimotoYoko ShiodaYozo Nakazawa Original Article 04 March 2023 Pages: 107 - 118
Detection of BRAF V600E mutation in radiological Langerhans cell histiocytosis-associated neurodegenerative disease using droplet digital PCR analysis Soichiro ShimizuKenichi SakamotoYoko Shioda Original Article 03 April 2023 Pages: 119 - 124
Human leukocyte antigen 7/8-matched unrelated bone marrow transplantation using anti-thymocyte globulin in children Motoharu HamadaHideki MuramatsuYoshiyuki Takahashi Original Article 07 March 2023 Pages: 125 - 130
Transformation of recurrent ALK-positive anaplastic large-cell lymphoma from common pattern to composite pattern (lymphohistiocytic and small-cell pattern) with a change in CD30 expression Liu JiCuiling LiuSha Zhao Case Report 03 February 2023 Pages: 131 - 134
Isolated relapse of plasma cell leukemia in the central nervous systems: a case report and literature review Takafumi OboKen MoritaMineo Kurokawa Case Report Open access 03 February 2023 Pages: 135 - 140
Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis Toru MiyajimaReiki OgasawaraTakeshi Kondo Case Report 23 January 2023 Pages: 141 - 145
FNAIT pathogenesis determined by serial analysis of three subsequent pregnancies of a woman with severe fetal and neonatal alloimmune thrombocytopenia (FNAIT) with anti-HPA-4b and anti-HPA-5b alloantibodies in the first sibling Tomoko KiyokawaKazuya MimuraHirokazu Kashiwagi Case Report 16 February 2023 Pages: 146 - 150
Correction: Recent progress in ITP treatment Francesco Rodeghiero Correction 30 May 2023 Pages: 151 - 151
